1Song YM, Sung J, Lawlor DA, Smith DG, Shin Y, Ebrahim S.Blood pressure, haemorrhagic stroke, and ischaemic stroke : the Korean national prospective occupational cohort study [J]. BMJ, 2004 ;328(7435): 324-325.
2He J, Whelton PK. Elevated systolic blood pressure and risk of cardiovascular and renal disease: overview of evidence from observational epidemiologic studies and randomized controlled trials[J ]. Am Heart J, 1999; 138(3 Pt2): 211 -219.
3Luscher TF, Cosentino F. The classification of calcium antagonists and their selection in the treatment of hypertension, A reappraisal[J].Drugs, 1998; 55(4): 509-517.
4Asmar R, Benetos A, Ghodsi N, Meilhac B, Safar M. Regional arterial hemodynamics and carotid circulation in essential arterial hypertension. Effect of nitrendipine in patients over 40 years of age[J].Presse Medicale, 1993 ; 22(35) : 1770 - 1775.
5Zanchetti A, Bond MG, Hennig M, Neiss A, Mancia G, Dal Palu C, et al. European Lacidipine Study on Atherosclerosis investigators.Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind,long-term trial[J ]. Circulation, 2002 ; 106 ( 19 ) : 2422 - 2427.
6Simon A, Gariepy J, Moyse D, Levenson J. Differential effects of nifedipine and co-amilozide on the progression of early carotid wall changes[J ]. Circulation, 2001 ; 103 (24) : 2949 - 2954.
7Neal B, MacMahon S, Chapman N. Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews ofrandomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration [ J ]. Lancet, 2000; 356(9246) : 1955 - 1964.
8Kaplan NM. Hypertension trials: 1990 to 2000[J]. Current Opinion in Nephrology & Hypertension, 2001 ; 10 ( 4 ) : 501 - 505.
9Opie LH, Schall R. Evidence-based evaluation of calcium channel blockers for hypertension: equality of mortality and cardiovascular risk relative to conventional therapy[Jl. Journal of the American College of Cardiology, 2002; 39(2): 315-322.
10Kloner RA, Vetrovec GW, Materson BJ, Levenstein M. Safety of long-acting dihydropyridine calcium channel blockers in hypertensive patients[J]. American Journal of Cardiology, 1998; 81 (2): 163-169.
2Steven E. Nissen,Stephen J. Nicholls,Ilks Sipahi,Peter Libby,Joel S. Raichlen,Christie M. Ballantyne,Jean Davignon,Raimund Erbel,Jean Charles Fruchart,Jean-Claude Tardif,Paul Schoenhagen,Tim Crowe,Valerie Cain,Kathy Wolski,Marlene Coormastic,E. Murat Tuzcu,仝其广（译）,王淑敏（译）,胡大一（校）.极高强度他汀治疗对冠状动脉粥样硬化消退的影响——ASTEROID试验[J].美国医学会杂志（中文版）,2006,25(4):215-223. 被引量：344
